1.- https://www.who.int/news-room/events/detail/2022/03/31/default-calendar/global-arbovirus-initiative
2.- Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases. Weaver SC, Charlier C, Vasilakis N, Lecuit M. Annu Rev Med. 2018 Jan 29;69:395-408. doi: 10.1146/annurev-med-050715-105122. Epub 2017 Aug 28. PMID: 28846489 Free PMC article. Review.
3.- Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya arboviruses: An update. Higuera A, Ramírez JD. Acta Trop. 2019 Feb;190:99-111. doi: 10.1016/j.actatropica.2018.11.010. Epub 2018 Nov 13. PMID: 30444971 Review.
4.- «BOE» núm. 65, de 17 de marzo de 2015, páginas 24012 a 24015 (4 págs.). BOE-A-2015-2837. https://www.boe.es/eli/es/o/2015/03/09/ssi445
5.- Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013).
6.- Rodriguez-Morales, A. J., Villamil-Gómez, W. E. & Franco-Paredes, C. The arboviral burden of disease caused by co-circulation and co-infection of dengue, chikungunya and Zika in the Americas. Travel Medicine and Infectious Disease 14, 177–179 (2016).
7.- https://www.who.int/es/news-room/fact-sheets/detail/zika-virus
8.- Fernandez-Garcia, M. D. et al. Chikungunya virus infections among travellers returning to Spain, 2008 to 2014. Eurosurveillance 21, 1–9 (2016).
9.- Spiteri, G., Sudre, B., Septfons, A. & Beauté, J. Surveillance of zika virus infection in the EU/EEA, june 2015 to january 2017. Eurosurveillance 22, 1–7 (2017).
10.- https://www.ecdc.europa.eu/en
11.- Susana Monge, Visitación García-Ortúzar, Begoña López Hernández, María Ángeles Lopaz Pérez, Sarah Delacour-Estrella, María Paz Sánchez-Seco, Beatriz Fernández Martinez, Lucía García San Miguel, Ana García-Fulgueiras, María José Sierra Moros, Dengue Outbreak Investigation Team. Characterization of the first autochthonous dengue outbreak in Spain (August-September 2018). Acta Trop. 2020 May;205:105402 DOI: 10.1016/j.actatropica.2020.105402. PMID: 32088276.
12.- Adhami, J. & Reiter, P. Introduction and establishment of Aedes (Stegomyia) albopictus skuse (diptera: culicidae) in Albania. J. Am. Mosq. Control Assoc. 14, 340–343 (1998).
13.- Aranda, C., Eritja, R. & Roiz, D. First record and establishment of the mosquito Aedes albopictus in Spain. Med. Vet. Entomol. 20, 150–152 (2006).
14.- Paupy, C., Delatte, H., Bagny, L., Corbel, V. & Fontenille, D. Aedes albopictus, an arbovirus vector: From the darkness to the light. Microbes Infect. 11, 1177–1185 (2009).
15. Preparación y respuesta de enfermedades transmitidas por vectores de dengue, chikungunya y Zika.
16.- Protocolo de Vigilancia de la enfermedad por virus Zika. [https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/PROTOCOLOS/PROTOCOLOS%20EN%20BLOQUE/PROTOCOLOS%20VECTORES/protocolos%202019/PROTOCOLO%20ZIKA_20190726.pdf]
17.- Protocolo de Vigilancia de la enfermedad por virus Dengue.
18.- Protocolo de Vigilancia de la enfermedad por virus Chikungunya.
19.- Protocolo de Vigilancia de la Fiebre Amarilla.
20. Perera R, Kuhn RJ. Structural proteomics of dengue virus. Curr Opin Microbiol. 2008 Aug;11(4):369-77. doi: 10.1016/j.mib.2008.06.004. Epub 2008 Jul 31. PMID: 18644250 Free PMC article. Review.
21.- Nader Raafat, Stuart D Blacksell, and Richard J Maude. A review of dengue diagnostics and implications for surveillance and control. Trans R Soc Trop Med Hyg. 2019 Nov; 113(11): 653–660. doi: 10.1093/trstmh/trz068
22.- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global
distribution and burden of dengue. Nature. 2013 Apr 25;496(7446):504–7.
24.- Muller DA, Depelsenaire ACI, Young PR. Clinical and laboratory diagnosis of dengue virus
infection. J Infect Dis. 2017;215(suppl_2):S89–95.
25.- World Health Organization. Dengue: guías para el diagnóstico, tratamiento, prevención
y control. Organización Mundial de la Salud; 2009.
26.- Martínez Yoldi MJ, Pérez Ruiz M, Sánchez-Seco Fariñas MP, et al. Diagnóstico microbiológico de las principales arbovirosis importadas y autóctonas. En: Cercenado Mansilla E, Cantón Moreno R, editores. Procedimientos en Microbiología Clínica. SEIMC; 2020.
27.- Paul Pielnaa, Moyed Al-Saadawe, Adonira Saro, Marcelllin Faniriantsoahenrio Dama, Mei Zhou, Yanxia Huang, Jufang Huang, Zanxian Xia. Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development. Virology. 2020 Apr;543:34-42.doi: 10.1016/j.virol.2020.01.015.
28.- https://www.who.int/es/news-room/fact-sheets/detail/zika-virus
29.- Guillaume A Durand, Géraldine Piorkowski, Laurence Thirion, Laetitia Ninove, Sandra Giron, Christine Zandotti, Jessica Denis, Cyril Badaut, Anna-Bella Failloux, Gilda Grard, Isabelle Leparc-Goffart, Xavier de Lamballerie. Vector-Borne Transmission of the Zika Virus Asian Genotype in Europe. Viruses. 2020 Mar 9;12(3):296. doi: 10.3390/v12030296.
30.- Gutierrez-Lopez R, Bialosuknia SM, Ciota AT, Montalvo T, Martinez-de la Puente J, Gangoso L, et al. Vector competence of Aedes caspius and Ae. albopictus mosquitoes for Zika virus, Spain. Emerg Infect Dis. 2019 Feb;25(2):346-8.
31.- Jansen S, Heitmann A, Luhken R, Jost H, Helms M, Vapalahti O, et al. Experimental transmission of Zika virus by Aedes japonicus japonicus from southwestern Germany. Emerg Microbes Infect. 2018 Nov 28;7(1):192.
32.- European Centre for Disease Prevention and Control. Zika virus disease in Var department, France – 16 October 2019. ECDC: Stockholm; 2019.
33.- Mariana Baz and Guy Boivin. Antiviral Agents in Development for Zika Virus Infections. Pharmaceuticals (Basel). 2019 Sep; 12(3): 101. doi: 10.3390/ph12030101
34.- Poland, Gregory A., Ovsyannikova, I.G., Kennedy, Richard B., 2019. Zika vaccine development: current status. https://doi.org/10.1016/j.mayocp.2019.05.016
35.- Azar SR, Campos RK, Bergren NA, Camargos VN, Rossi SL. Epidemic Alphaviruses: Ecology, Emergence and Outbreaks. Microorganisms. 2020 Aug 1;8(8):1167. doi: 10.3390/microorganisms8081167.
36. Powers A, Brault A, Shirako Y, Strauss E, Kang W, Strauss J, et al. Evolutionary relationships and systematics of the alphaviruses. J Virol. 2001;75:10118–10131. doi: 10.1128/JVI.75.21.10118-10131.2001.
37.- Sarawut Khongwichit, Jira Chansaenroj, Chintana Chirathaworn, Yong Poovorawan. Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries. J Biomed Sci. 2021 Dec 2;28(1):84.doi: 10.1186/s12929-021-00778-8.
38- Bonilauri P, Bellini R, Calzolari M, et al. Chikungunya virus in Aedes albopictus, Italy. Emerg Infect Dis 2008; 14:852–4.
39.-https://www.who.int/es/news-room/fact-sheets/detail/chikungunya
40.- https://www.ecdc.europa.eu/en/all-topics-z/chikungunya-virus-disease/surveillance-threats-and-outbreaks/autochthonous
41.- Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A. Chikungunya: epidemiology, pathogenesis, clinical features, management, and prevention. Infect Dis Clin N Am. 2019;33(4):1003–25.
42.- Johnson BW, Russell BJ, Goodman CH. Laboratory diagnosis of chikungunya virus infections and commercial sources for diagnostic assays. J Infect Dis. 2016;214(Suppl 5):471–4.
43.- Álvarez-Argüelles ME, Alba SR, Pérez MR, Riveiro JAB, García SM. Diagnosis and molecular characterization of chikungunya virus infections. Curr Top Negl Trop Dis. 2019. https:// doi. org/ 10. 5772/ intec hopen. 86957.
44.- Natalia Ingrid Oliveira Silva, Lívia Sacchetto, Izabela Maurício de Rezende, Giliane de Souza Trindade, Angelle Desiree LaBeaud, Benoit de Thoisy, Betânia Paiva Drumond. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease. Virol J. 2020 Jan 23;17(1):9. doi: 10.1186/s12985-019-1277-7.
45.- https://www.paho.org/es/temas/fiebre-amarilla
46.- Florian Douam and Alexander Ploss. Yellow fever virus: Knowledge gaps impeding the fight against an old foe. Trends Microbiol. 2018 November ; 26(11): 913–928. doi:10.1016/j.tim.2018.05.012.
47.- Chen, L.H.; Wilson, M.E. Yellow fever control: Current epidemiology and vaccination strategies. Trop. Dis. Travel Med. Vaccines 2020, 6, 1.
48.- https://www.who.int/es/news-room/fact-sheets/detail/yellow-fever
49.- https://www.ecdc.europa.eu/en/yellow-fever/facts
50.- Organizacion Mundial de la Salud. Clinical Management of Patients with Yellow Fever. Interims Guidance. Geneva; 2016
51.- Jesse J Waggoner, Alejandra Rojas, Benjamin A Pinsky. J Clin Microbiol. Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat. 2018 Sep 25;56(10):e00827-18. doi: 10.1128/JCM.00827-18.